Headache
Headache: a pain in any region of the head. Headaches may occur on one or both sides of the head, be isolated to a certain location, radiate across the head from one point, or have a viselike quality. A headache may appear as a sharp pain, a throbbing sensation or a dull ache.
What's Popular in Headache
-
JAN 18, 2020Cancer
JAN 18, 2020Have you fallen for the turmeric craze? That little orange root that yellows your fingers when you peel it has become very popular recently for its medicin...WRITTEN BY: Kathryn DeMuth SullivanJAN 08, 2020Clinical & Molecular DX
JAN 08, 2020Intense, debilitating pain that can last for days. Nausea, numbness and sensitivity to light. For people who experience migraines, it’s frustrating t...WRITTEN BY: Tara FernandezDEC 27, 2019Drug Discovery & Development
DEC 27, 2019Over 1 in 10 people around the world- or 780 million people. Three times more common in women than in men, until now, most treatments have been preventativ...WRITTEN BY: Annie LennonDEC 22, 2019Drug Discovery & Development
DEC 22, 2019The U.S Food and Drug Administration has now approved a new medication for migraines. The drug is called ‘ubrogepant (Ubrelvy)’ and comes in th...WRITTEN BY: Nouran AminDEC 20, 2019Neuroscience
DEC 20, 2019Research is increasingly pointing towards the importance of the gut-brain axis in regulating our health. Not only has the health of our gut bacteria, or mi...WRITTEN BY: Annie Lennon
JAN 18, 2020
Cancer
JAN 18, 2020
Have you fallen for the turmeric craze? That little orange root that yellows your fingers when you peel it has become very popular recently for its medicin...
WRITTEN BY:
Kathryn DeMuth Sullivan
JAN 08, 2020
Clinical & Molecular DX
JAN 08, 2020
Intense, debilitating pain that can last for days. Nausea, numbness and sensitivity to light. For people who experience migraines, it’s frustrating t...
WRITTEN BY:
Tara Fernandez
DEC 27, 2019
Drug Discovery & Development
DEC 27, 2019
Over 1 in 10 people around the world- or 780 million people. Three times more common in women than in men, until now, most treatments have been preventativ...
WRITTEN BY:
Annie Lennon
DEC 22, 2019
Drug Discovery & Development
DEC 22, 2019
The U.S Food and Drug Administration has now approved a new medication for migraines. The drug is called ‘ubrogepant (Ubrelvy)’ and comes in th...
WRITTEN BY:
Nouran Amin
DEC 20, 2019
Neuroscience
DEC 20, 2019
Research is increasingly pointing towards the importance of the gut-brain axis in regulating our health. Not only has the health of our gut bacteria, or mi...
WRITTEN BY:
Annie Lennon
DEC 08, 2019
Drug Discovery & Development
DEC 08, 2019
Pimavanserin, also known as Nuplazid, was approved in the US to treat Parkinson’s-related psychosis in 2016. Now, new research has shown that it also...
WRITTEN BY:
Annie Lennon
NOV 26, 2019
Cannabis Sciences
NOV 26, 2019
Innovative technology allowed researchers to conduct the first-ever study of cannabis use for the treatment of headache and migraine pain in real-time. Wit...
WRITTEN BY:
Kara Marker
OCT 23, 2019
Drug Discovery & Development
OCT 23, 2019
Researchers at the University of South Carolina's Arnold School of Public Health have reported that repurposing existing FDA-approved antiviral drugs o...
WRITTEN BY:
Nouran Amin
OCT 23, 2019
Health & Medicine
OCT 23, 2019
Adolescent screen-time is an intensely debated topic. New research from McMaster University has added more fuel to that fire and gives parents another reas...
WRITTEN BY:
Tiffany Dazet
-
JAN 14, 2020 9:00 AM PSTC.E. CREDITS
JAN 14, 2020 9:00 AM PSTFecal elastase-1 – a biomarker for pancreatic exocrine insufficiency(EPI) continues to gain traction as an ideal biomarker for assessing EPI. This presentation will include a review of...Speaker: Roy Sherwood, BSc, MSC, DPhilPresented at:Discover More; Your Virtual ResourceSponsored By: Diasorin, Inc.
Hyper and Hypoparathyroid diseases are often latent conditions with significant morbidity and at times mortality. The symptoms range from the obvious, such as kidney stones, bone fractures, a...Speaker: D Sudhaker Rao, MB,BS, FACP, FACEPresented at:Discover More; Your Virtual ResourceSponsored By: DiaSorin
JAN 14, 2020
9:00 AM PST
C.E. CREDITS
JAN 14, 2020
9:00 AM PST
Fecal elastase-1 – a biomarker for pancreatic exocrine insufficiency(EPI) continues to gain traction as an ideal biomarker for assessing EPI. This presentation will include a review of...
Speaker:
Roy Sherwood, BSc, MSC, DPhil
Presented at:Discover More; Your Virtual Resource
Sponsored By: Diasorin, Inc.
Hyper and Hypoparathyroid diseases are often latent conditions with significant morbidity and at times mortality. The symptoms range from the obvious, such as kidney stones, bone fractures, a...
Speaker:
D Sudhaker Rao, MB,BS, FACP, FACE
Presented at:Discover More; Your Virtual Resource
Sponsored By: DiaSorin
-
JUN 25, 2018C.E. CREDITS
JUN 25, 2018Welcome to our virtual site where you can Discover More about DiaSorin...
JUN 25, 2018
C.E. CREDITS
JUN 25, 2018
Welcome to our virtual site where you can Discover More about DiaSorin...